Skip to content

SCHEDULE 13GAccepted Feb 7, 4:01 PM ET

Maze Therapeutics, Inc. SCHEDULE 13G

Foresite Capital Fund IV, L.P.

Accepted (ET)

4:01 PM

Feb 7, 2025

Filed

Feb 7, 2025

Documents

1

Size

18.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.